BrightSpring Hlth Svcs saw its IBD SmartSelect Composite Rating rise to 97 Wednesday, up from 94 the day before.
Looking For Winning Stocks? How To Invest In Both Bull And Bear Markets
The upgrade means the stock is now outpacing 97% of all other stocks in terms of key performance metrics and technical strength.
BrightSpring Hlth Svcs is currently forming a cup without handle, with a 24.82 entry. Look for the stock to break out in heavy trade at least 40% higher than normal.
The stock earns an 80 EPS Rating, meaning its recent quarterly and annual earnings growth tops 80% of all stocks.
Its Accumulation/Distribution Rating of A shows heavy buying by institutional investors over the last 13 weeks.
The company posted a 0% EPS gain for Q1. Top line growth came in at 26%, down from 29% in the prior quarter.
BrightSpring Hlth Svcs earns the No. 1 rank among its peers in the Medical-Outpatient/Home Care industry group. Encompass Health and Fresenius Medical Care are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
